Varicella zoster virus vasculopathy: Clinical features and pathogenesis

Journal of NeuroVirology

Volumn 20, Issue 2, 2014, Pages 157-163

  Nagel, Maria A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Herpes virus; Neuropathology; VZV vasculopathy

Indexed keywords

B LYMPHOCYTE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN VASCULITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS PATHOGENESIS;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; MACROPHAGES; STROKE;

EID: 84898904828     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0183-9     Document Type: Review

References (41)

1. Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden D (1995) The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 37:784-790
2. Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Andrew M, Curtis R, Meaney B, deVeber G (2001) Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 32:1257-1262
3. Braun KP, Bulder MM, Chabrier S, Kirkham FJ, Uiterwaal CS, Tardieu M, Sébire G (2009) The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 32:544-557
4. Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW (2001) IFN-gamma action in the media of the great elastic arteries: a novel immunoprivileged site. J Clin Invest 107:R15-R22
5. Devinsky O, Cho ES, Petito CK, Price RW (1991) Herpes zoster myelitis. Brain 114:1181-1196
6. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC (1997) Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402:111-115
7. Frid MG, Brunetti JA, Burke DL, Carpetner TC, Davie NJ, Reeves JT, Roedersheimer MT, van Rooijen N, Stenmark KR (2006) Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168:659-669
8. Gilden DH, Vafai A, Shtram Y, Becker Y, Devlin M, Wellish M (1983) Varicella-zoster virus DNA in human sensory ganglia. Nature 306:478-480
9. Gilden D, Beinlich BR, Rubinstien EM, Stommel E, Swenson R, Rubinstein D, Mahalingam R (1994) Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44:1818-1823
10. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R (1996) Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 47:1441-1446
11. Gilden DH, Gesser R, Smith J, Wellish M, Laguardia JJ, Cohrs RJ, Mahalingam R (2001) Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 23:145-147
12. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8:731-740
13. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2010) Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 342:243-253
14. Gray F, Mohr M, Rozenberg F, Belec L, Lescs MC, Dournon E, Sinclair E, Scaravilli F (1992) Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of four cases. Neuropathol Appl Neurobiol 18:502-514
15. Gray F, Bélec L, Lescs MC, Chrétien F, Ciardi A, Hassine D, Flament-Saillour M, de Truchis P, Clair B, Scaravilli F (1994) Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 117:987-999
16. Hartney T, Birari R, Venkataraman S, Villegas L, Martinez M, Black SM, Stenmark KR, Nozik-Grayck E (2011) Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells: model to test impact of extracellular ROS in chronic hypoxia. PLoS One 6:e27531
17. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D (2010) Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: case report and review of the literature. J Neurol Sci 292:85-88
18. Hsieh CC, Yen MH, Yen CH, Lau YT (2001) Oxidized low-xdensity lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res 49:135-145
19. Hyman RW, Ecker JR, Tenser RB (1983) Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 2:814-816
20. Itoh Y, Nagase H (1995) Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 270:16518-16521
21. Kang JH, Ho JD, Chen YH, Lin HC (2009) Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 40:3443-3448
22. Kennedy PG, Grinfeld E, Gow JW (1998) Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 95:4658-4662
23. Li J, Li W, Su J, Liu W, Altura BT, Altura BM (2003) Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes. Brain Res Bull 62:101-106
24. Lin HC, Chien CW, Ho JD (2010) Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 74:792-797
25. Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D (1990) Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 323:627-631
26. Mathias M, Nagel MA, Khmeleva N, Boyer PJ, Choe A, Durairaj VD, Bennett JL, Mandava N, Gilden D (2013) VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis, and temporal artery infection in the absence of zoster rash. J Neurol Sci 325:180-182
27. Morgello S, Block GA, Price RW, Petito CK (1988) Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 112:173-177
28. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH (2007) The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069-1073
29. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani B, Schiller A, Safdieh JE, Kamenkovich E, Ostrow LW, Levy M, Greenberg B, Russman AN, Katzan I, Gardner CJ, Häusler M, Nau R, Saraya T, Wada H, Goto H, de Martino M, Ueno M, Brown WD, Terborg C, Gilden DH (2008) The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70:853-860
30. Nagel MA, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, VanEgmond EM, Stenmark K, Frid M, Mahalingam R, Wellish M, Choe A, Cordery-Cotter R, Cohrs RJ, Gilden D (2011) Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 77:364-370
31. Nagel MA, Russman AN, Feit H, Traktinskiy I, Khmeleva N, Schmid DS, Skarf B, Gilden D (2013a) VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology 80:220-222
32. Nagel MA, Bennett JL, Khmeleva N, Choe A, Rempel A, Boyer PJ, Gilden D (2013b) Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology 80:2017-2021
33. Nagel MA, Choe A, Khmeleva N, Overton L, Rempel A, Wyborny A, Traktinskiy I, Gilden D (2013c) Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries. J Neurovirol 19(2):181-5
34. Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, Choe A, Gilden D (2013d) Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology 80:62-68
35. Okada G, Nakanishi Y (1989) Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin I. FEBS Lett 249:353-356
36. Petito CK, Cho ES, Lemann W, Navia BA, Price RW (1986) Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45:635-646
37. Ryder JW, Croen K, Kleinschmidt-DeMasters BK, Ostrove JM, Straus SE, Cohn DL (1986) Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol 192:182-188
38. Salazar R, Russman AN, Nagel MA, Cohrs RJ, Mahalingam R, Schmid DS, Kleinschmidt-DeMasters BK, VanEgmond EM, Gilden D (2011) Varicella zoster virus ischemic optic neuroxpathy and subclinical temporal artery involvement. Arch Neurol 68:517-520
39. Stenmark KR, Frid MG, Yeager M, Li M, Riddle S, McKinsey T, El Kasmi KC (2012) Targeting the adventitial microenvironment in pulmonary hypertension: a potential approach to therapy that considers epigenetic change. Pulm Circ 2:3-14
40. Stevens DA, Ferrington RA, Jordan GW, Merigan TC (1975) Cellular events in zoster vesicles: relation to clinical course and immune parameters. J Infect Dis 131:509-515
41. Weber DS, Taniyama Y, Rocic P (2004) Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 94:1219-1226